全文获取类型
收费全文 | 34540篇 |
免费 | 9257篇 |
国内免费 | 190篇 |
专业分类
耳鼻咽喉 | 335篇 |
儿科学 | 913篇 |
妇产科学 | 681篇 |
基础医学 | 6364篇 |
口腔科学 | 1150篇 |
临床医学 | 4668篇 |
内科学 | 8334篇 |
皮肤病学 | 731篇 |
神经病学 | 2888篇 |
特种医学 | 1965篇 |
外科学 | 7603篇 |
综合类 | 363篇 |
一般理论 | 15篇 |
预防医学 | 3574篇 |
眼科学 | 555篇 |
药学 | 1867篇 |
1篇 | |
中国医学 | 44篇 |
肿瘤学 | 1936篇 |
出版年
2021年 | 599篇 |
2020年 | 418篇 |
2019年 | 423篇 |
2018年 | 662篇 |
2017年 | 619篇 |
2016年 | 770篇 |
2015年 | 1123篇 |
2014年 | 1827篇 |
2013年 | 2546篇 |
2012年 | 1251篇 |
2011年 | 1179篇 |
2010年 | 1557篇 |
2009年 | 1590篇 |
2008年 | 957篇 |
2007年 | 823篇 |
2006年 | 916篇 |
2005年 | 798篇 |
2004年 | 715篇 |
2003年 | 616篇 |
2002年 | 643篇 |
2001年 | 760篇 |
2000年 | 675篇 |
1999年 | 872篇 |
1998年 | 894篇 |
1997年 | 843篇 |
1996年 | 889篇 |
1995年 | 846篇 |
1994年 | 733篇 |
1993年 | 660篇 |
1992年 | 789篇 |
1991年 | 763篇 |
1990年 | 675篇 |
1989年 | 752篇 |
1988年 | 737篇 |
1987年 | 741篇 |
1986年 | 683篇 |
1985年 | 684篇 |
1984年 | 606篇 |
1983年 | 574篇 |
1982年 | 613篇 |
1981年 | 583篇 |
1980年 | 549篇 |
1979年 | 564篇 |
1978年 | 545篇 |
1977年 | 539篇 |
1976年 | 468篇 |
1975年 | 422篇 |
1974年 | 390篇 |
1973年 | 369篇 |
1972年 | 362篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
41.
Ignacio Lopez Escolastico Aguilera-Tejero Arnold J Felsenfeld Jose Carlos Estepa Mariano Rodriguez 《Journal of bone and mineral research》2002,17(9):1691-1700
Because both metabolic (Met Acid) and respiratory acidosis (Resp Acid) have diverse effects on mineral metabolism, it has been difficult to establish whether acidosis directly affects parathyroid hormone (PTH) secretion. Our goal was to determine whether acute Met Acid and Resp Acid directly affected PTH secretion. Three groups of dogs were studied: control, acute Met Acid induced by HCl infusion, and acute Resp Acid induced by hypoventilation. EDTA was infused to prevent acidosis-induced increases in ionized calcium, but more EDTA was needed in Met Acid than in Resp Acid. The PTH response to EDTA-induced hypocalcemia was evaluated also. Magnesium needed to be infused in groups receiving EDTA to prevent hypomagnesemia. The half-life of intact PTH (iPTH) was determined during hypocalcemia when PTH was measured after parathyroidectomy. During normocalcemia, PTH values were greater (p < 0.05) in Met Acid (92 +/- 19 pg/ml) and Resp Acid (77 +/- 22 pg/ml) than in controls (27 +/- 5 pg/ml); the respective pH values were 7.23 +/- 0.01, 7.24 +/- 0.01, and 7.39 +/- 0.02. The maximal PTH response to hypocalcemia was greater (p < 0.05) in Met Acid (443 +/- 54 pg/ml) than in Resp Acid (267 +/- 37 pg/ml) and controls (262 +/- 48 pg/ml). The half-life of PTH was greater (p < 0.05) in Met Acid than in controls, but the PTH secretion rate also was greater (p < 0.05) in Met Acid than in the other two groups. In conclusion, (1) both acute Met Acid and Resp Acid increase PTH secretion when the ionized calcium concentration is normal; (2) acute Met Acid may increase the bone efflux of calcium more than Resp Acid; (3) acute Met Acid acts as a secretogogue for PTH secretion because it enhances the maximal PTH response to hypocalcemia. 相似文献
42.
43.
The authors report the association of erythroleukemia (FAB M6) and fetal hemoglobin (HbF) level of at least 65% after therapy for ovarian carcinoma. The patient's erythrocytes had many signs of reversion to fetal-like erythropoiesis including: elevated HbF with a fetal G gamma/A gamma (gly/ala) of 3/1, low hemoglobin A2 (HbA2), macrocytosis, and increased i antigen. These data and data from other case reports suggest that elevation of HbF to greater than 25% with reversion to fetal-like erythropoiesis is useful in differentiating erythroleukemia from other preleukemic disorders. 相似文献
44.
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies
Bayard L. Powell Hyman B. Muss Robert L. Capizzi Mary E. Caponera Douglas R. White Patricia J. Zekan James N. Atkins Don V. Jackson Jr. Frederick Richards II John B. Craig Julia M. Cruz Charles L. Spurr 《Cancer chemotherapy and pharmacology》1987,19(3):250-252
Summary Cytosine arabinsodie (ara-C) and etoposide (VP-16) display synergy in the laboratory. Twenty-six patients participated in a phase I study of high-dose ara-C in combination with VP-16. The dose of VP-16 was held constant at 50 mg/m2 as an intermittent infusion over 33 h; escalating doses of ara-C were given as infusions during hours 9–12 and 21–24. Myelosuppression was the dose-limiting toxicity and occurred with doses considerably less than those expected from studies of the two drugs as single agents. The suggested initial doses for phase II trials with this schedule are 750 mg/m2×2 doses of ara-C and 50 mg/m2 of VP-16. Nonhematologic toxicity was minimal; therefore, further dose escalation is feasible in patients in whom myelosuppression is acceptable.Supported in part by grants from the National Cancer Institute (CA-12197 and CA-09422) and the American Cancer Society CF-85-182 相似文献
45.
Immunologic and pharmacologic concepts of monoclonal antibodies 总被引:2,自引:0,他引:2
Lionel S. Zuckier Lorna D. Rodriguez Matthew D. Scharff 《Seminars in nuclear medicine》1989,19(3):166-186
While monoclonal antibodies have solved many of the difficulties of using immunologic reagents for radioimmunodiagnosis and therapy, in the 13 years since their introduction a number of persistent problems remain, most notably a low yield of antibody-producing cells from the fusion process, difficulty in obtaining high-affinity antibodies, and the potential immunogenicity of murine immunoglobulins (Igs). Several solutions are under development, including fusion techniques that enrich for cells producing desired antibodies, production of human-mouse chimeric antibodies by recombinant DNA technology, and the generation of human monoclonal antibodies by promising new approaches. Until these upcoming methodologies are established, and to better direct their development and application, a sound understanding of the pharmacology of presently available native and modified monoclonal antibodies is crucial. Although much has been already determined in this area, a great deal of further clarification remains necessary. 相似文献
46.
47.
48.
Performance characteristics of pooled rabbit IgG polyclonal anti-C3d are compared with one mouse IgM and three mouse IgG monoclonal anti-C3d antibodies (MAs). IgG MA,s employed singly or in combination, failed to precipitate C3d; by contrast, IgM MA and polyclonal anti-C3d precipitated C3d. Measurements of polyclonal anti-C3d concentration by chemical means and by 125I-C3d radioimmunoassay (RIA) agreed closely. RIA values were 50% of chemical measurement values for three of the four MAs. Use of sucrose density gradient ultracentrifugation to assess MA C3d/anti-C3d molar combining ratios for soluble anti-C3d/C3d was not possible because fast-sedimenting multimeric C3d/anti-C3d complexes did not form. Dissociation and competitive binding studies indicate that (1) two MAs had substantially lower affinities than the other anti-C3d antibodies, and (2) polyclonal anti-C3d recognizes more C3d epitopes than are recognized by individual MAs. The results demonstrate antigenic complexity of C3d fragment and illustrate the difficulties of predicting individual MA performance based on prior experience with polyclonal antibodies. 相似文献
49.
50.
ngela P. de Mattos Tereza C.M. Ribeiro Patrícia S.A. Mendes Sandra S. Valois Carlos M.C. Mendes Hugo C. Ribeiro Jr 《Nutrition Research》2009,29(7):462-469
Although previous studies have shown successful treatment of persistent diarrhea (PD) with the use of yogurt-based diets, some recent ones speculate the need of special formulas for the nutritional management of PD complicated cases. In the present study, we tested the hypothesis that the consumption of 3 lactose-free diets, with different degrees of complexity, is associated with lower stool output and shorter duration of diarrhea when compared with the use of a yogurt-based one on the nutritional management of PD. A total of 154 male infants, aged between 1 and 30 months, with PD and with or without dehydration, were randomly assigned to 1 of 4 treatment groups. Throughout the study, the patients were placed in a metabolic unit; their body weights and intakes of oral rehydration solution, water, and formula diets, in addition to outputs of stool, urine, and vomit, were measured and recorded at 24-hour intervals. Four different diets were used in this study: diet 1, yogurt-based formula; diet 2, soy-based formula; diet 3, hydrolyzed protein-based formula; and diet 4, amino acid–based formula. Throughout the study, only these formula diets were fed to the children. The data showed that children fed the yogurt-based diet (diet 1) or the amino acid–based diet (diet 4) had a significant reduction in stool output and in the duration of diarrhea. The use of an inexpensive and worldwide-available yogurt-based diet is recommended as the first choice for the nutritional management of mild to moderate PD. For the few complicated PD cases, when available, a more complex amino acid–based diet should be reserved for the nutritional management of these unresponsive and severe presentations. Soy-based or casein-based diets do not offer any specific advantage or benefits and do not seem to have a place in the management of PD. 相似文献